Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer
Status:
Withdrawn
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety of Zaltrap in patients who undergo
pre-operative chemotherapy with Zaltrap. The investigators hypothesize that Zaltrap my impact
colorectal cancer growth and metastasis.